Brief: Nascent Biotech To Begin Animal Model Studies For Pritumumab Against Coronaviruses And Covid-19

Nascent Biotech

17/06/2020 14:17

June 17 (Reuters) - Nascent Biotech Inc  NBIO.PK :
    * NASCENT BIOTECH TO BEGIN ANIMAL MODEL STUDIES FOR
PRITUMUMAB
AGAINST CORONAVIRUSES AND COVID-19

Source text for Eikon:  ID:nGNXP783s 
Further company coverage:  NBIO.PK 

 ((Reuters.Briefs@thomsonreuters.com;))